Vertical AI Agents: The Business Model Replacing Enterprise Workflows
Vertical AI agents are replacing entire enterprise workflows — not augmenting them. This investor brief breaks down the revenue model, competitive moats, and deal selection signals behind the fastest-growing category in enterprise AI. Built for VC, PE, family offices, and the C-suite.
The Metrics That Will Matter More Than Headlines This Year
Discover the 3 business metrics that predict long-term success better than growth rates. Learn why stress-tested burn multiple, deployment velocity, and switching costs matter more than user acquisition for building durable, profitable companies in 2025.
Bio + AI Convergence: Synthetic Biology, Generative Drug Design & Programmable Cells
Biology became programmable in 2025. AI synthetic biology hit $94.73M, growing to $438M by 2034. Unilever ships bio-cleaners, BASF invests €600M annually. Companies reprogram cells for rocket fuel, materials. Master this convergence or face obsolescence.